Detalhe da pesquisa
1.
Impact of Gemcitabine Plus S1 Neoadjuvant Chemotherapy on Borderline Resectable Perihilar Cholangiocarcinoma.
Ann Surg Oncol
; 29(4): 2393-2405, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-34994885
2.
Our Rationale of Initiating Neoadjuvant Chemotherapy for Hilar Cholangiocarcinoma: A Proposal of Criteria for "Borderline Resectable" in the Field of Surgery for Hilar Cholangiocarcinoma.
World J Surg
; 43(4): 1094-1104, 2019 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-30536024
3.
A Simple and Easily Reproducible Model of Reversible Obstructive Jaundice in Rats.
In Vivo
; 33(3): 699-706, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31028186
4.
Efficacy of prolonged elemental diet therapy after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma: A pilot prospective randomized trial (UMIN000004108).
Clin Nutr ESPEN
; 34: 116-124, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31677701
5.
Single-institution experience with gemcitabine-cisplatin combination therapy as a second-line treatment for patients with unresectable biliary tract cancer after failure of gemcitabine-S-1 combination therapy: a prospective feasibility study.
Cancer Chemother Pharmacol
; 81(5): 949-955, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29594362